Telostrand: UroMIR TM PCa Panel

Telostrand’s UroMiR™ PCa panel is a patent-pending urine-based laboratory developed molecular diagnostic test (LDT) that measures the expression of specific microRNAs (miRNAs) associated with genes involved in prostate cancer. MiRNAs are small, stable RNA molecules found in bodily fluids that reflect underlying biological processes, including cancer development. Our test uses the quantitative PCR (qPCR) methodology to detect and measure miRNA’s associated with prostate cancer. Once results are populated, we can determine the possible risk of developing prostate cancer.